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Protein Kinase D Regulates the Fission of
Cell Surface Destined Transport Carriers
from the Trans-Golgi Network
bg subunits containing all isoforms from bovine brains.
The exact isoform of bg that causes Golgi vesiculation
therefore is not known. It is interesting to note that there
are two additional isoforms of PKD and these are called
PKD2 and PKDn, respectively (Hayashi et al., 1999; Stur-
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La Jolla, California 92093 any et al., 2000). While PKD is localized to the Golgi
apparatus (in addition to the cytosol and plasma mem-†Afdeling Biochemie
Faculteit Geneeskunde brane), the precise intracellular locales of PKD2 and
PKDn are not known. However, all of these kinases haveCampus Gasthuisberg
Katholieke Universiteit Leuven similar structural features (two cysteine rich domains, a
pleckstrin homology domain, and a catalytic domain). GbgHerestraat, B-3000 Leuven
Belgium is known to activate a number of intracellular components
including the phospholipid-dependent enzymes such as
phosphoinositide 3 kinases (Maier et al., 2000). Addition-
ally, the mixture of Gbg subunits used in our assay mostSummary
likely activate all three (and other hitherto unidentified)
isoforms of PKD and thus catalyze the en masse vesicu-When a kinase inactive form of Protein Kinase D (PKD-
lation of Golgi stacks. Therefore, while these studiesK618N) was expressed in HeLa cells, it localized to
have revealed the involvement of the trimeric G proteinthe trans-Golgi network (TGN) and caused extensive
subunit bg and PKDs in regulating membrane fission,tubulation. Cargo that was destined for the plasma
the specificity of these components and the order inmembrane was found in PKD-K618N-containing tubes
which they act along the pathway regulating membranebut the tubes did not detach from the TGN. As a result,
fission is not clear. The stacks of Golgi cisternae com-the transfer of cargo from TGN to the plasma mem-
municate via transport carriers with the endoplasmicbrane was inhibited. We have also demonstrated the
reticulum (ER), endosomes, and the plasma membrane.formation and subsequent detachment of cargo-con-
Is the formation of transport carriers destined for thesetaining tubes from the TGN in cells stably expressing
compartments regulated by different isoforms of PKD?low levels of PKD-K618N. Our results suggest that
In order thus to understand the specificity of these ki-PKD regulates the fission from the TGN of transport
nases and their involvement in the bona fide process ofcarriers that are en route to the cell surface.
intracellular protein transport we have now examined
the role of PKD by using a kinase inactive form of PKDIntroduction
(PKD-K618N).
We have found that expression of PKD-K618N causesA mechanism must exist to balance the organization of
tubulation of the TGN and the cargo specifically destinedGolgi stacks during protein transport. Otherwise, the
to the plasma membrane is found in the TGN-derived,Golgi stacks risk the possibility of conversion into trans-
PKD-K618N-containing tubes. However, the tubes doport carriers. We have identified a marine sponge metab-
not detach from the TGN. As a result, transfer of cargoolite called ilimaquinone (IQ), which when added to ver-
from the TGN to the plasma membrane is inhibited.tebrate cells converts Golgi stacks into small vesicles
Under these conditions, protein transport from the endo-(Takizawa et al., 1993). Simply put, IQ tips the balance
plasmic reticulum (ER) to the late Golgi compartments,in the direction of uncontrolled membrane fission and
from the TGN to the endosomes, and to the ER is notthe stacks are converted into small vesicles. We rea-
affected. The PKD-K618N-containing, TGN-derived tubessoned that analysis of IQ-mediated reactions should
are not coated with clathrin or the COP1 components.reveal the mechanisms regulating membrane fission.
We have generated a stable cell line of HeLa cellsFurthermore, we suggested that the fission process acti-
expressing moderate levels of PKD-K618N (HeLazvated by IQ treatment is the same as that utilized to form
GF17). When these cells are cultured at 378C, PKD-transport carriers from Golgi stacks under physiological
K618N is found on the TGN, the plasma membrane, andconditions (Takizawa et al., 1993; Jamora et al., 1997,
the cytosol. At this temperature, there is no obvious1999). The IQ-mediated Golgi vesiculation was reconsti-
effect on the organization of the Golgi apparatus. How-tuted in permeabilized cells and found to involve the
ever, when these cells are shifted to 208C, PKD-K618Ntrimeric G protein subunit bg (Jamora et al., 1997). Fur-
is found localized mostly on the TGN and the corre-ther analysis revealed that bg binds to the pleckstrin
sponding membranes are tubulated. Protein transporthomology (PH) domain of a serine/threonine kinase
from the TGN to the cell surface is blocked under thesecalled protein kinase D (PKD) and that this interaction
conditions. Interestingly, upon shifting these cells to 25–causes vesiculation of Golgi stacks (Jamora et al., 1999).
378C, the PKD-K618N-containing tubes detach from theIn our studies, we have used a purified preparation of
TGN. These tubes eventually fuse with the plasma mem-
brane and the cargo that was trapped in PKD-K618N-‡ To whom correspondence should be addressed (e-mail: malhotra@
containing tubes is delivered to the plasma membrane.biomail.ucsd.edu).
§ These authors contributed equally to this work. Our findings illustrating the role of PKD in the fission
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Figure 1. PKD-K618N Localizes to the Golgi
Apparatus and Causes Extensive Tubulation
(A) GST-tagged wt PKD and PKD-K618N
were expressed in 293T cells. The proteins
were isolated by adsorption on anti-GST col-
umn from the cell lysates and incubated with
32P-ATP for 10 min at 328C. The kinase reac-
tion and the radioactivity associated with the
respective kinases were carried out as de-
scribed previously (Jamora et al., 1999). Top
panel (1), autophosphorylation of PKD; bot-
tom panel (2), coomassie blue staining to
show the amounts of respective proteins
used in this experiment. PKD-K618N is less
than 2% active in autophosphorylation com-
pared with the wt PKD.
(B) HeLa cells expressing GSTzPKD-K618N
or wt GSTzPKD were visualized by staining
with the anti-GST antibody. The wt PKD is
found in the pericentriolar Golgi apparatus
and diffusely dispersed in the cytoplasm (a).
PKD-K618N is found predominantly in the
pericentriolar Golgi apparatus and the Golgi-
associated tubes (b).
(C) HeLa cells were cotransfected with 5 mg
of PKD-K618N and increasing amounts of wt
PKD. The cells were visualized after 72 hr
by fluorescence microscopy using anti-GST
antibody. Coexpression of wt PKD prevents
the PKD-K618N-mediated Golgi tubulation.
(D) HeLa cells expressing GSTzwt PKD or
GSTzPKD-K618N were stained with an anti-TGN46 and anti-PKD antibody. The cells were visualized by fluorescence microscopy. Localization
of TGN46 and wt GST-PKD (a and b) in HeLa cells expressing wt PKD; localization of TGN46 and PKD-K618N in GSTzPKD-K618N expressing
HeLa cells (c and d) is shown.
of transport carriers specifically from the TGN are de- diffusely dispersed in the cytosol (Figure 1B). This con-
firms our previous findings and those of others that ascribed below.
significant fraction of PKD localizes to the Golgi appara-
tus (Prestle et al., 1996; Jamora et al., 1999). Unlike wtResults
PKD, PKD-K618N is almost entirely localized to the Golgi
apparatus and on the tubes emanating from the GolgiThe PKD Inactive Kinase (PKD-K618N) Localizes
to the Trans-Golgi Network apparatus (Figure 1B). The transfection efficiency in
these experiments is between 50% and 70% of cellsand Promotes Tubulation
PKD is tightly associated with the Golgi membranes and and the Golgi apparatus tubulated in 40%, 60%, and
85% of the transfected cells after 24 hr, 48 hr, and 72additionally present in the cytosol (Prestle et al., 1996;
Jamora et al., 1999). The levels of PKD are low in HeLa hr, respectively, of transfection. For the experiment de-
scribed below, 200 cells on duplicate coverslips werecells compared with other cell types (Johannes et al., 1994;
Jamora and Malhotra, unpublished). We reasoned that counted to document the organization of the Golgi appa-
ratus but, for the sake of convenience, only one cell/expressing a kinase inactive form of PKD would be dom-
inant over the low levels of endogenous PKD in these figure is shown.
To test whether the tubulation of the Golgi apparatuscells. These cells would therefore provide an opportunity
to test the in vivo significance of PKD. A mutant form is specifically due to PKD-K618N expression, HeLa cells
were cotransfected with 5 mg of PKD-K618N and in-of PKD was generated by replacing Lysine 618 with
Asparagine (K618N) in the ATP binding site of its cata- creasing amounts of the wt PKD. Visualization of the
cells by fluorescence microscopy using anti-GST anti-lytic domain. This form cannot bind ATP and is therefore
inactive as a protein kinase (Zugaza et al., 1996; Waldron body revealed that wt PKD effectively competes with
the tubulation activity of the kinase inactive PKD-K618Net al., 1999). To confirm this, the GST-conjugated wild-
type (wt) and PKD-K618N were expressed in 293T cells. (Figure 1C). These findings illustrate that there is a strong
connection between the kinase activity of PKD and theThe proteins were isolated by adsorption on GSTz
beads and tested for their ability to undergo autophos- Golgi tubulation.
The wt PKD and PKD-K618N show best colocalizationphorylation (a test for the kinase activity of PKD). PKD-
K618N is less than 2% active in autophosphorylation with TGN46 of the TGN, compared with other Golgi-
specific markers such as Giantin, GRASP 65, GM130,compared with the wt PKD (Figure 1A).
HeLa cells transfected with either the GSTzPKD- and Mannosidase II (Figure 1D and data not shown).
Interestingly, TGN46 is found in the PKD-K618N-con-K618N or the wt GSTzPKD were stained with anti-GST
antibodies. GSTzPKD localizes to a pericentriolar re- taining tubes. TGN46 is ordinarily transported from TGN
to the plasma membrane and then back to the TGN viagion, the plasma membrane, and is additionally found
PKD-Mediated Transport Carrier Formation
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Figure 2. PKD-K618N Expression Inhibits Pro-
tein Transport from Golgi Apparatus to the
Cell Surface
(A) HeLa cells were cotransfected with
GSTzPKD-K618N and CD4. CD4 is made in
the ER and transported to the cell surface via
the Golgi apparatus. The cells were costained
with anti-GST antibody and OKT4 antibody
to visualize GSTzPKD-K618N and CD4, re-
spectively. PKD-K618N is found on the Golgi
apparatus and the associated tubes (c). CD4
is retained in the Golgi apparatus and the
associated tubes and not found at the cell
surface (b). In cells expressing CD4 only, as
expected, the protein is found at the cell sur-
face (a).
(B) CD4 has two oligosaccharide chains,
which undergo core glycosylation in the ER.
The ER-specific form of CD4 is endo H sensi-
tive. Upon reaching the Golgi apparatus, one
of its oligosaccharide chains undergoes mat-
uration by the Golgi-specific glycosyltrans-
ferases. The medial and post medial cister-
nae form of CD4 is resistant to digestion with
endo H. In control cells (expressing CD4 only), CD4 becomes fully endo H resistant 2 hr after pulse labeling of the newly synthesized proteins.
CD4 in cells expressing both CD4 and PKD-K618N also becomes fully endo H resistant after 2 hr of the pulse labeling. Thus PKD-K618N
expression does not affect the transport of CD4 from ER to the medial cisternae of the Golgi apparatus. R and S denote the endo H resistant
and sensitive forms of the oligosaccharide chains, respectively.
endosomes (Banting and Ponnambalam, 1997). Thus, labeled with 35S-methionine for 15 min at 378C and sub-
sequently incubated with medium containing unlabeledPKD-K618N expression in HeLa cells causes its localiza-
tion predominantly to the TGN. Under these conditions, methionine. CD4 was immunoprecipitated after 0, 30,
60, and 120 min from these cells. One half of the precipi-the TGN is tubulated and the tubes contain the recycling
protein TGN46. tate was incubated with endo H and the other half with
buffer alone. Endo H treated and untreated CD4 samples
were analyzed by SDS-PAGE/autoradiography. Our re-Protein Transport from the Trans-Golgi Network
to the Cell Surface Is Inhibited in Cells sults show that the newly synthesized CD4 in cells ex-
pressing PKD-K618N acquires resistance to endo H withExpressing PKD-K618N
HeLa cells were cotransfected with PKD-K618N and the same kinetics as in cells not expressing PKD-K618N
(Figure 2B). Thus, CD4 is transported across the GolgiCD4. The latter is an integral membrane protein that is
made in the ER and transported to the cell surface via stacks to at least the medial Golgi cisternae in cells
expressing PKD-K618N.Golgi apparatus (Nilsson et al., 1989). The transfected
cells were visualized by fluorescence microscopy using
antibodies against the respective proteins. In PKD- PKD-K618N Expression Neither Inhibits Protein
Transport from TGN to the Endosomes norK618N expressing cells, CD4 is contained in the Golgi
apparatus and in Golgi-associated PKD-K618N-con- Affects the Organization of ER, the Transitional
ER, and the Intermediate Compartmenttaining tubes. However, CD4 does not reach the cell
surface under these conditions (Figure 2Ab). In control HeLa cells were cotransfected with PKD-K618N and
H2-M. H2-M is a resident protein of endosomes/lyso-cells (i.e., not expressing PKD-K618N), CD4 is found at
the cell surface (Figure 2Aa). somes. It is made in the ER and transported to endo-
somes via the Golgi apparatus (Karlsson et al., 1994).Is CD4 retained in the cis-Golgi cisterna or does it
travel across the Golgi stack and fail to exit from the HeLa cells expressing PKD-K618N and H2-M were
stained with the respective antibodies and visualizedTGN? To address this issue, the following experiment
was carried out. CD4 is core glycosylated at two sites by fluorescence microscopy. In cells expressing H2-M
alone, it is localized to punctate structures (Figure 3Aa).in the ER. The ER-specific oligosaccharide chains of
CD4 are sensitive to digestion with the enzyme endogly- These punctate structures are the endosomes/lyso-
somes as shown previously (Karlsson et al., 1994). Coex-cosidase H (endo H). During its transport along the Golgi
stacks, one of its oligosaccharide chains undergoes fur- pression of PKD-K618N does not affect the transport of
H2-M to similar punctate structures (Figure 3Ab). Addi-ther processing by the Golgi-specific glycosyltransfer-
ases. This particular oligosaccharide chain of CD4 in tionally, there is no accumulation of H2-M in ER and
the Golgi apparatus in PKD-K618N expressing cells. Athe medial and post-medial Golgi cisternae, therefore,
becomes resistant to digestion with endo H. This change defect in transport of H2-M to endosomes would cause
its accumulation in the compartments en route. How-in sensitivity to endo H treatment, therefore, provides a
useful assay to map the location of CD4 in the Golgi ever, one could argue that the endosomal localized
H2-M is a fraction of the protein that reached therestacks. HeLa cells were cotransfected with PKD-K618N
and CD4 or with CD4 alone. After 72 hr, the cells were prior to the expression of PKD-K618N at threshold levels
Cell
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Figure 3. PKD-K618N Expression Neither
Blocks Protein Transport from the Golgi Ap-
paratus to the Endosomes nor Affects the
Organization of Other Compartments of the
Secretory Pathway
(A) HeLa cells were cotransfected with PKD-
K618N and the endosomal resident protein
H2-M. These proteins were visualized by fluo-
rescence microscopy with specific antibod-
ies to PKD and H2-M, respectively. H2-M is
found in small punctate structures (b) in cells
expressing PKD-K618N, which are similar to
control cells expressing H2-M only (a).
(B) HeLa cells were transfected with the In-
variant chain p35 only (a), cotransfected with
GSTzPKD-K618N and p35 (b and c) or with
GST-PKD-K618N only (e, f, h, and i). The cells
were stained with antibodies to p35 (an ER
marker in [a]); p35 and GST (b and c); Sec13p
(d); Sec13p and GST (e and f); ERGIC53 (g);
ERGIC53 and GST (h and i). Expression of
PKD-K618N does not perturb the organiza-
tion nor does it cause tubulation of the com-
partments containing p35 (ER marker), Sec13
(transitional ER marker), and p53 (ERGIC 53
or the intermediate compartment marker).
necessary for inhibiting this transport step. To address calization of the KDEL receptor, which cycles between
ER and the Golgi apparatus via the intermediate com-this potential concern, the following experiment was
carried out. PKD-K618N was cotransfected with the en- partment, is unaffected in cells expressing PKD-K618N
(data not shown).dosomal marker H2-M. H2-M was under the tetracy-
cline-inducible promoter. H2-M was induced 16 hr after HeLa cells were cotransfected with GSTzPKD-K618N
and the Invariant chain p35 (an ER marker; Kuwana etPKD-K618N transfection to ensure that tubulation had
occurred before H2-M reached the Golgi apparatus. al., 1998), or transfected with PKD-K618N alone. The
cells were stained with anti-GST antibody to visualizeAfter 72 hr, the cells were visualized by fluorescence
microscopy using antibodies to the proteins H2-M and PKD-K618N and antibodies to the compartment-spe-
cific markers such as anti-p35 antibody, Sec13p anti-PKD, respectively. Under these experimental condi-
tions, the Golgi membranes were tubulated and H2-M body (a marker for the transitional ER; Hammond and
Glick, 2000), and ERGIC53 antibody (p53, an intermedi-was found in the endosomes (data not shown). Thus,
PKD-K618N expression does not affect protein trans- ate compartment-specific protein; Schindler et al.,
1993). The cells were visualized by fluorescence micros-port from ER to the endosomes via TGN.
Expression of PKD-K618N does not affect the recy- copy. Our results show that expression of PKD-K618N
has no obvious effect on the organization of compart-cling of proteins from Golgi apparatus to the intermedi-
ate compartment and to the ER. This is evident from our ments of the secretory pathway preceding the Golgi
apparatus (Figure 3B).findings that the organization of ERGIC53 (p53), which
cycles between the intermediate compartment and the PKD-K618N expression does not affect the organiza-
tion of early and late endosomes as monitored by fluo-early Golgi cisternae (cis/medial), is unaffected in cells
expressing PKD-K618N (Figure 3B). In addition, the lo- rescence microscopy using anti-EEA1 antibody (for
PKD-Mediated Transport Carrier Formation
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Figure 4. The Tubulated Golgi Membranes
Do Not Contain COP1 and Clathrin Coats
(A) HeLa cells were transfected with
GSTzPKD-K618N and the cells double la-
beled with antibodies to the COP1-specific
subunit b-COP or clathrin. The normal local-
ization of clathrin and b-COP in nontrans-
fected HeLa cells is shown in (a) and (d). In
cells expressing PKD-K618N, the clathrin (b)
and b-COP (e) staining is evident in the core
of the Golgi apparatus. The PKD-K618N-con-
taining tubes in these cells (c and f) do not
contain clathrin or the b-COP.
(B) HeLa cells expressing GFPzPKD-K618N
were permeabilized and incubated with GTPgS
(a and b). The cells were stained with the anti-
b-COP antibody. PKD-K618N-coated tubes do
not contain b-COP (b). HeLa cells were perme-
abilized and treated with BFA in the absence
(c) or the presence of GTPgS (d). GTPgS pre-
vents the BFA-mediated dissociation of b-COP
(d). Thus, GTPgS is functional in promoting
COP1 coating of the Golgi membranes under
our experimental conditions.
early endosomes) and anti-LAMP1 antibody (for late en- found on the Golgi apparatus but not the tubes con-
taining PKD-K618N (Figure 4A). The localization of b-COPdosomes and lysosomes) (data not shown).
Taken together, these results provide very strong evi- in control (nontransfected) cells to the Golgi apparatus
and punctate structures (presumably, the VTC’s) isdence for the effects of PKD-K618N expression on pro-
tein transport and tubulation, specifically to its locale of shown in Figure 4A for comparison. Therefore, unlike
BFA treatment, the expression of PKD-K618N doesthe TGN.
not result in the dissociation of COP1 coats from Golgi
apparatus.PKD-K618N-Induced TGN Tubes Do Not Contain
b-COP or Clathrin While b-COP is required to form COP1-coated vesi-
cles, clathrin is needed for the formation of clathrin-coatedThe cytosolic proteins ARF and COP1 coats are required
to form the COP1 vesicles from Golgi cisternae (Orci vesicles from the TGN. HeLa cells expressing PKD-K618N
and costained with the anti-clathrin antibody revealedet al., 1993). Treatment with Brefeldin A (BFA) causes
dissociation of COP1 coats from the Golgi apparatus. that clathrin colocalizes with the core of PKD-K618N-
containing TGN but not the tubes (Figure 4A).The Golgi membranes tubulate and eventually fuse with
the ER (Lippincott-schwartz et al., 1989). PKD-K618N Our results show that PKD-K618N-containing tubes
originate in the TGN and lack clathrin and COP1 coats.expression causes tubulation of the TGN, but the tubes
do not fuse with the target membrane. We, therefore, This fits well with our findings that expression of PKD-
K618N does not affect protein transport from TGN to thesought to test whether the tubes generated by PKD-
K618N expression are COP1 coated. HeLa cells express- endosomes (which is mediated by clathrin-coated vesi-
cles) and to the ER (which is mediated by COP1 vesi-ing PKD-K618N were stained with an anti-b COP antibody
and visualized by fluorescence microscopy. b-COP is cles). However, we reasoned that coats might dissociate
Cell
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once the PKD-K618N-containing tubes had reached a 90% of the cells (Figure 5). While PKD-K618N-containing
tubes attached to the TGN are evident in these cells,certain dimension. This is a reasonable argument since
it is known that COP1 coats dissociate rapidly after the the cells are also found to contain short PKD-K618N-
containing tubules detached from the TGN. These shortformation of COP1 vesicles (Orci et al., 1989). To address
this issue, we made use of the finding that treatment fragmented tubules may be the result of incomplete
inhibition of the fission process during the shift fromwith the nonhydrolyzable analog of GTP, namely GTPgS,
prevents uncoating (Melancon et al., 1987; Malhotra et 378C to 208C. In control cells, i.e., cells not expressing
PKD-K618N, tubulation of the TGN was observed (byal., 1989). HeLa cells were transfected with GFPzPKD-
K618N and two days after the transfection, cells were staining with the anti-TGN46 antibody) in fewer than
10% of the cells (data not shown). Thus, tubulation ofpermeabilized with digitonin and incubated with 100 mM
GTPgS for 30 min at 328C. A control consisted of the TGN at 208C is a quantitative effect of PKD-K618N
expression. In HeLazGF17 cells, the tubes remainGFPzPKD-K618N-expressing cells that were perme-
abilized and incubated with the buffer used for dissolv- attached to the Golgi apparatus even after an additional
3 hr of incubation at 208C in 60% of the cells. But if,ing GTPgS. The cells were visualized by fluorescence
microscopy with anti-bCOP antibody. While the core of after 2 hr of incubation at 208C, the cells are shifted to
258C (or to a higher temperature of 378C) for 30 min, thethe Golgi apparatus contains b-COP, the PKD-K618N-
containing tubes are devoid of b-COP (Figure 4B). Thus, tubes are found detached from the Golgi apparatus in
70% of the cells. After 3 hr of incubation at higher tem-under conditions that promote binding of COP1 coats to
the Golgi membranes, the PKD-K618N-containing Golgi peratures (25–378C), the Golgi membranes appear nor-
mal, i.e., without any tubulation, in greater than 70%tubes are uncoated and remain attached to the TGN.
To test whether GTPgS is effective in coating the Golgi of the cells (Figure 5). Thus, there is a temperature-
dependent formation and dissociation of the PKD-membranes with COP1 coats, the following experiment
was carried out. As mentioned above, one of the earliest K618N-containing tubes in these cells. PKD cycles be-
tween the cytosol and the Golgi apparatus. A simpleeffects of Brefeldin A (BFA) treatment is the loss of COP1
coats from the Golgi apparatus. However, treatment with explanation for our findings is that there is a tempera-
ture-sensitive defect in the recycling of PKD. In HeLazGTPgS inhibits the BFA-mediated shedding of COP1
coats (Donaldson et al., 1992). HeLa cells were perme- GF17 cells, PKD-K618N binds to the Golgi apparatus
and then dissociates at 378C. However, because of theabilized, incubated with GTPgS, and then treated with
BFA. The cells were visualized with the anti-b-COP anti- low levels of PKD-K618N expression, there is little no-
ticeable effect on the organization of TGN at 378C. Whenbody. In control cells (not treated with GTPgS), b-COP
dissociates from the Golgi apparatus by BFA treatment the cells are shifted to 208C, PKD-K618N binds to the
TGN but fails to dissociate. Thus, it accumulates on the(Figure 4B). In cells treated with GTPgS, bCOP remains
attached to the Golgi membranes in the presence of Golgi membranes and acts as dominant negative over
the low levels of endogenous kinase. Upon shift to 378C,BFA. Therefore, GTPgS is effective in promoting the
binding (and retention) of COP1 coats under our experi- the cycling of PKD-K618N is restored, the tubes dissoci-
ate, and the Golgi apparatus returns to its normal organi-mental conditions. These findings lend further support
to our proposal that PKD-K618N-containing tubes are zation. This temperature-dependent accumulation and
subsequent detachment of the PKD-K618N tubes illus-derived from the TGN, are en route to the plasma mem-
brane, and do not contain COP1 and clathrin coats. trates that these tubes are not a dead end product but
a kinetic intermediate in the TGN to the cell surface step
of the transport process.The Accumulation and Consumption
of PKD-K618N-Containing, TGN-Derived Tubes
The data presented above suggest that a domain of The PKD-K618N-Containing Tubes Are
Intermediates in Protein Transportthe TGN tubulates when the kinase activity of PKD is
compromised. The tubes contain cargo destined for the from TGN to the Cell Surface
Do PKD-K618N-containing tubes carry cargo from TGNcell surface but fail to dissociate. But are these tubes
the transport carriers in the TGN to the cell surface step to the cell surface in HeLazGF17 cells? HeLazGF17
cells were infected with the tsO45 strain of vesicularof the secretory pathway? If so, we should be able to
find conditions in which these tubes detach from the stomatitis virus (VSV). At the nonpermissive temperature
of 408C, the VSV-G protein is made and retained in theTGN and fuse with the plasma membrane. We have
designed an experimental strategy to address precisely endoplasmic reticulum. This is because of a tempera-
ture-sensitive defect in the folding of VSV-G protein.this issue. We have generated a stable line of HeLa
cells that express moderate levels of GSTzFLAGzPKD- Upon shifting the cells to 208C, the VSV-G protein folds
and is transported along the secretory pathway to aK618N. These cells, called HeLazGF17, express full-
length GSTzFLAG-PKD-K618N (data not shown). Fluo- late Golgi compartment (Griffiths et al., 1985). However,
protein transport from the late Golgi compartment to therescence microscopic analysis with anti-GST antibody
of these cells reveals that a fraction of PKD-K618N is cell surface is blocked under these conditions. Shifting
cells to a temperature of 25–328C restores protein trans-localized to the Golgi apparatus. In addition, PKD-
K618N is found at the cell surface and the cytosol. These port from the late Golgi compartments to the cell sur-
face. The mechanism by which transport from the TGNcells show no obvious defect in the organization of the
Golgi apparatus at 378C (Figure 5). When these cells are is blocked at 208C is not known but it provides a useful
means to monitor protein transport along this step. Wemaintained at 208C for 2–3 hr, the PKD-K618N-con-
taining TGN undergo extensive tubulation in greater than carried out this experiment in HeLazGF17 cells. Newly
PKD-Mediated Transport Carrier Formation
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Figure 5. The Temperature-Sensitive Accumulation and Detachment of PKD-K618N-Containing Tubes
HeLa cells stably expressing GSTzFLAGzPKD-K618N (HelazGF17) were incubated at 208C for 2 hr. The cells were then kept at 208C or
shifted to 258C and 378C. The cells were stained with anti-GST antibody after 30 min and 3 hr of incubation at the respective temperatures.
Control cells incubated at 378C show the localization of PKD-K618N to the Golgi apparatus, the cytosol, and the plasma membrane. Shifting
the cells to 208C causes extensive tubulation of the Golgi apparatus and the tubes are PKD-K618N coated. Within 30 min of incubation at
258C and 378C, the PKD-K618N-containing short tubes are detached from the core of PKD-K618N staining TGN. After 3 hr of incubation at
258C and 378C, the Golgi apparatus appears almost normal. However, in cells kept at 208C, the PKD-K618N-containing tubes remain attached
to the TGN.
synthesized VSV-G protein was arrested in the late Golgi conditions, the TGN46 is found in PKD-K618N tubes
(Figure 7). The tubes are attached to the TGN at thiscompartment by the 208C temperature block for 2 hr in
the presence of cycloheximide. The cells were shifted to stage of the incubation. After 30 min of incubation at
25–378C, the PKD-K618N- and TGN46-containing mem-258C and visualized by fluorescence microscopy using
anti-VSV-G and GST antibodies. Immediately upon shift branes are found detached from the Golgi apparatus
(data not shown). Taken together, these findings illus-from 208C to the 258C (0 min time point, Figure 6), the
VSV-G protein is found in PKD-K618N tubes attached trate that PKD-K618N-containing tubes are the carriers
of cargo such as VSV-G protein and TGN46 from TGNto the Golgi apparatus. At 20–30 min of incubation at
258C, the PKD-K618N and VSV-G protein-containing to the cell surface in HeLazGF17 cells.
tubes are found detached from the Golgi apparatus.
After 60 min of incubation at 258C, the PKD-K618N and Discussion
VSV-G protein-containing small membranes are found
closer to the plasma membrane. In fact, at this time in The identity of transport carriers from TGN to the cell
surface (other than the secretory storage granules) andabout 20% of the cells, the VSV-G protein can be de-
tected at the cell surface. At 90 min, in greater than 70% the mechanism by which they form is largely unknown.
This is in contrast to the well-characterized COP1,of the cells, the VSV-G protein is found at the cell surface.
At this time point, the number of PKD-K618N tubes is COPII, and clathrin-coated vesicles. In all of these latter
cases, their formation is shown to require a small molec-markedly reduced and PKD relocates to the Golgi appa-
ratus, cytosol, and the plasma membrane (Figure 6). ular weight GTPase and a complex of cytosolic proteins
called the coat proteins (COP1, COPII, and clathrinAs mentioned above, TGN46 cycles between TGN and
the endosomes via the plasma membrane. In HeLa cells coats). In contrast, we have found that when the kinase
activity of PKD is compromised by overexpressing anexpressing PKD-K618N by transient transfection, TGN46
is trapped in PKD-K618N-containing tubes (Figure 1D). inactive kinase (PKD-K618N), the cargo contained in the
TGN is captured into tubes but the tubes do not detach.In HeLazGF17 cells kept at 378C, the TGN46 colocalizes
with the Golgi-associated pool of PKD-K618N and the By using a stable cell line expressing low levels of PKD-
K618N, we have shown that PKD-K618N-containingGolgi membranes appear normal, i.e., without any obvi-
ous tubes (Figure 7). HeLazGF17 cells were shifted to tubes are transport intermediates from TGN to the
plasma membrane.208C for 2 hr and visualized by fluorescence microscopy
using anti-TGN46 and anti-PKD antibodies. Under these We have reconstituted the accumulation and subse-
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Figure 6. A Time-Dependent Detachment
and Consumption of Cargo-Containing PKD-
K618N Tubes in HeLazGF17
HeLazGF17 cells were infected with the
tsO45 strain of VSV at 328C. The cells were
shifted to 408C for 2.5 hr, to 328C for 25 min,
and then to 208C for 2 hr. The cells were then
transferred to 258C. At the time points shown,
the cells were fixed and stained with the anti-
VSV-G and GST antibody to visualize VSV-G
protein and PKD-K618N, respectively. At the
onset of the reaction at 258C, VSV-G protein
and PKD-K618N-containing tubes are found
attached to the TGN. This is also evident after
20 min of incubation. However, by 30 min
of incubation at 258C, the two proteins are
contained in small tubes and punctate ele-
ments that are not attached to the Golgi ap-
paratus. By 90 min, VSV-G protein is detected
at the cell surface in greater than 70% of the
cells. At this time point PKD-K618N relocates
to the Golgi and the cytosol. The boxed areas
are examples showing colocalization of
VSV-G and PKD-K618N.
quent consumption of the PKD-K618N-containing tubes the 208C incubation inhibits protein exit from the TGN
is not known. Under these conditions, the cargo des-in a temperature-dependent manner. It has been known
for a number of years that protein transport from the tined to the cell surface remains in the TGN but there
is no detectable tubulation. However, in cells expressinglate Golgi compartments to the cell surface is blocked
at 208C (Griffiths et al., 1985). The mechanism by which PKD-K618N (HeLazGF17), the TGN undergoes exten-
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nase inactive form of PKD (PKD-K618N) causes tubula-
tion because of a defect in membrane fission. But why
does treatment with IQ and bg convert Golgi stacks into
vesicles whereas PKD-K618N expression affects only a
subset of the TGN? One possibility is that IQ and the
mixture of bg used in our studies activate other compo-
nents (in addition to PKD, PKD2, and PKDn) and thus
have a more global effect on the Golgi stacks. PKDwt
and PKD-K618N, on the other hand, localize predomi-
nantly on the TGN and therefore affect only the TGN-
specific processes.
The Partners of PKD Regulating the Formation
of Transport Carriers from the TGN
The formation of PKD-K618N-containing tubes from the
TGN does not seem to involve COP1 or clathrin coats.
GTPgS treatment, which promotes coating and fission
of COP1-coated membranes, has no effect on the PKD-
K618N-containing tubes. The PKD-dependent, TGN-
Figure 7. The Recycling Protein TGN46 Is Contained in the TGN-
derived tubes, therefore, are either uncoated or containDerived PKD-K618N Tubes in HeLazGF17 Cells
a novel coat.HelazGF17 cells were incubated at 378C and then shifted to 208C
What is downstream of PKD? We have previouslyfor 2 hr. The cells were stained with anti-GST and TGN46 antibodies.
proposed that different combinations of protein and lipidTGN46 and PKD-K618N are found in tubes attached to the Golgi
apparatus at 208C. kinases regulate the formation of transport carriers with
distinct destinations from the Golgi apparatus (Jamora
et al., 1999). The Vps15p (a protein kinase) and Vps34p
sive tubulation. The tubes containing cargo destined for (PI-3 kinase) combination is involved in the generation
the cell surface accumulate as a result of PKD-K619N of clathrin-coated vesicles from TGN to the endosomes
expression in these cells at 208C. Upon shifting the cells (Stack et al., 1995). We believe that phosphoinositide
to 258C, the tubes detach from TGN and eventually fuse kinases are also involved in the PKD-mediated, but
with the cell surface. A likely possibility is that the 208C clathrin- and COP1-independent, transport carrier for-
incubation inhibits recycling of PKD-K618N and, over a mation from the TGN. Support for this proposal comes
time period of 2–3 hr, causes its accumulation on the from two recent findings. First, PKD is known to interact
TGN. This creates a situation in which transport carriers with at least two different lipid kinases. These are a type
form but fail to undergo fission, consequently accumu- II phosphatidylinositol 4 kinase (PI-4 K) and phosphati-
lating as tubes attached to the TGN. When these cells dylinositol-4-phosphate 5 kinase (P1-4 P 5K). The PKD
are transferred to higher temperatures (25–378C), the kinase activity is essential for this association and/or
cycling of PKD-K618N between the TGN and the cytosol activation (Nishikawa et al., 1998). Second, PI-4 kinases
is restored, the tubes detach from the TGN and eventu- are required for secretion from TGN to the cell surface
ally fuse with the cell surface, thus restoring protein in yeast (Hama et al., 1999; Walch-Solimena and Novick,
trafficking between these two compartments. These 1999; Audhya et al., 2000). Identification of the PI kinases
findings suggest a pivotal role of PKD in regulating the that match with PKD will help address this issue.
fission (detachment) of cargo-containing tubular ele-
ments from TGN to the cell surface. A Pathway for Regulating the Formation
of Transport Carriers from the TGN
In summary, our findings have revealed the significancePKD-Mediated Membrane Fission Is
Highly Compartmentalized of PKD-mediated reactions in the fission of transport
carriers from the TGN. A regulated fission process could,PKD was identified as a component of the Golgi vesicu-
lation process that is triggered by treatment with ilima- in principle, control the number and size of transport
carriers budding from the TGN (and other intracellularquinone (Jamora et al., 1999). We have shown that IQ
treatment activates a trimeric G protein on the Golgi compartments of the exocytic and endocytic pathways).
For example, if the cargo is large, the process of mem-apparatus. Sequestering Gbg with GazGDP inhibits IQ-
mediated Golgi fragmentation. Adding purified bovine brane fission could be delayed until the transport carrier
is large enough—a tubule for example—to encapsulatebrain bg subunits without treatment with IQ causes frag-
mentation of the Golgi apparatus. These results suggest the cargo. Remember tubules as transport carriers from
the Golgi to the cell surface have been visualized, butthat bg subunits regulate the equilibrium between the
Golgi apparatus as stacks of cisternae and as vesicles their molecular description and the mechanism of for-
mation are not known (Cooper et al., 1990; Glick and(Jamora et al., 1997). Further studies revealed that PKD
was the downstream target of bg subunits (Jamora et Malhotra, 1998; Hirschberg et al., 1998; Toomre et al.,
1999; Polishchuk et al., 2000). From a mechanistic pointal., 1999). In other words, overactivation of PKD via IQ
and bg subunits converts Golgi stacks into vesicles of view, the difference between a small vesicle and large
tube (as transport carriers) may simply be in the timingthrough uncontrolled activation of the fission machinery.
It, therefore, makes sense that overexpression of a ki- of membrane fission. But is the signal for determining
Cell
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a fusion protein. pEGFP-PKD-K618N was constructed by subclon-the size of the transport carriers dictated solely by the
ing the SalI-SmaI fragment from pGMEXT3-PKD-K618N into pEGFP-cargo? And once this decision is made, how is the reac-
C1 vector (Clontech).tion terminated to prevent the compartment from con-
The clones CD4 (Nilsson et al., 1989), H2-M (Karlsson et al., 1994),
version into transport carriers? These are appealing sug- and p35 (Kuwana et al. 1998) were as described in the papers refer-
gestions and issues of fundamental importance, but little enced.
is known to validate their applicability during protein
transport. It is clear that in order to gain a comprehensive Antibodies
For the PKD immunofluorescence staining, either a rabbit polyclonalunderstanding of the mechanisms regulating the bal-
anti-PKD antibody or a Goat polyclonal GST antibody was used.ance between secretory load and the compartmental
The anti-PKD antibody is a rabbit polyclonal antibody generatedintegrity, we need to identify other essential components
against EEREMKALSERVSIL, the C-terminal peptide of PKD. The
and place the currently known players, such as bg, PKD, anti-GST antibody was purchased from Amersham Pharmacia Bio-
and PI-kinases, in the correct order. The placement of tech Inc. For the experiments involving CD4, either OKT4 or anti-
human CD4 monoclonal antibody (R and D MAB 379) was used.PKD in the fission of tubes from the TGN adds a molecu-
Ascites fluid containing mouse monoclonal antibody OKT4 was pre-lar component and paves the way for an understanding
pared using hybridoma No. CRL-8002 from ATCC. The anti-CD107aof regulating membrane fission in this key step of protein
antibody was purchased from PharMingen. The anti-EEA1 antibodytransport.
was purchased from Transduction Laboratories. The anti-TGN46
antibody is a gift from Dr. Vas Ponnambalam (Leeds University),
Experimental Procedures
ERGIC 53 antibody from Dr. Hans-Peter Hauri (University of Basel,
Switzerland). The b-COP mouse monoclonal antibody CM1A10 was
Cell Culture and Transfections
a gift from Dr. Jim Rothman (Sloan-Kettering Institute). The rat
Hela cells were cultured in Dulbecco’s modified Eagle’s medium
monoclonal H2-M antibody was a gift from Dr. Lars Karlsson (The
(DMEM, GIBCO) supplemented with 10% FCS, 2 mM glutamine, and
RW Johnson Research Institute). The anti-p35 antibody is a mouse
100 U/ml penicillin and streptomycin at 100 mg/ml, and passaged
monoclonal antibody called Pin-1 and a gift from Dr. Peter Cresswell
every other day. For VSV transport, this media was supplemented
(Yale University). The anti-Sec13 antibody is a rabbit polyclonal
with 25 mM Hepes buffer, pH 7.4. Transient transfections were car-
antibody and a gift from Dr. William Balch (The Scripps Research
ried out using the calcium phosphate method as previously de-
Institute). The anti-clathrin antibody is a rabbit polyclonal antibody
scribed (Liljedahl et al., 1996); a total of 25 mg of DNA and 5 x 105
and a gift from Dr. Sandra Schmidt (The Scripps Research Institute).
cells were used per transfection. The following amounts of DNA
The anti-VSV-G antibody called P5D4 (against the intracellular por-
were used for transfections: Figures 1A and 1B, 25 mg wt PKD and
tion of the VSV-G) has been documented previously (Jamora et al.,
25 mg PKD-K618N; Figures 1Da and 1Db, 25 mg wt PKD; Figures
1999), the anti VSV-G antibody called 8G5F11(against the extracellu-
1Dc and 1Dd, 25 mg PKD-K618N; Figure 2Aa, 5 mg CD4 and 20 mg
lar portion of VSV-G) is a gift from Dr. Lyles (Wake Forest University).
mock DNA; Figures 2Ab and 2Ac, 5 mg CD4 and 20 mg PKD-K618N;
Secondary antibodies, goat anti-rabbit, anti-mouse, and goat anti-
Figure 2B, same as in Figure 2A; Figure 3Aa, 2.5 mg H2-Ma, 2.5 mg
rat were obtained from Cappel. Donkey anti-goat, anti-rabbit, anti-
H2-Mb (this protein exits as a dimer of a and b subunits), and 20
mouse, and anti-sheep antibodies were obtained from Jackson Im-
mg mock DNA; Figures 3Ab and 3Ac, 2.5 mg H2-Ma, 2.5 mg H2-Mb,
muno Research.
and 20 mg PKD-K618N; Figure 3Ba, 5 mg p35 and 20 mg mock DNA;
Figures 3Bb and 3Bc, 5 mg p35 and 20 mg PKD-K618N; Figures 3Be,
Transport of VSV-G Protein in Hela Cells Stably Expressing3Bf, 3Bh, and 3Bi, 25 mg PKD-K618N; Figures 4Ab, 4Ac, 4Ae, and
PKD-K618N (HelazGF17)4Af, 25 mg PKD-K618N; Figures 4Ba and 4Bb, 25 mg GFPzPKD-
The experiment was carried out as described previously (JamoraK618N.
et al., 1999) with the following changes. Briefly, HeLazGF17 cells
in 24-well plate were incubated with 0.5 ml DMEM without FCS-Generation of the Stable Cell Line Expressing PKD-K618N
containing Hepes, VSV for 1 hr at 328C, followed by additional 45Hela cells were transfected with pME-Neo-GF-PKD-K618N using the
min incubation with 1.5 ml complete DMEM. The cells were thencalcium phosphate method. Selection with 500 mg/ml G418 (GIBCO)
shifted to 408C for 2.5 hr, 328C for 25 min, 208C for 2 hr, and finallybegan two days after transfection, followed by limiting dilution to
258C for the times indicated.establish cell lines. One cell line, GF17, expressed full-length GST-
FLAG tagged PKD-K618N analyzed by Western blotting (data not
Immunoprecipitation of PKD and the Kinase Assayshown) and immunofluorescence microscopy using anti-GST anti-
by Autophosphorylationbody and the antibody recognizing the C-terminal portion of PKD.
For the experiment shown in Figure 1A, 293T cells transfected with
GST-tagged PKD wt or PKD-K618N expression plasmid were lysedPulse Chase Experiment to Analyze the Transport of CD4
in lysis buffer (20 mM Tris pH 7.4, 150 mM NaCl, 1 mM EDTA, 1%Hela cells were transfected as indicated above. 72 hr after transfec-
NP-40, 0.25% deoxycholate, 1 mM DTT, 25 mM NaF, 5 mM Na4P2O7,tion, cells were first starved for 30 min in methionine-free media
1 mM PMSF, 2 mg/ml Leupeptin, 0.2 mg/ml aprotinin, and 0.2 mg/and then pulse labeled in media containing 0.1 mCi 35S-methionine
ml pepstatin) for 1 hr at 48C, followed by centrifugation at 100,000 3 g(NEN, Life Science Products) per ml for 15 min. The cells were
for 30 min. The lysates were incubated overnight with Glutathione-subsequently incubated in regular media containing methionine for
sepharose (Amersham Pharmacia, Uppsala, Sweden). The precipi-30, 60, and 120 min. At the times mentioned, the cells were lysed
tates were washed three times with lysis buffer and twice with elutionin RIPA buffer and CD4 protein immunoprecipitated (see below),
buffer (20 mM Tris pH 7.4, 150 mM NaCl, 1 mM EDTA, 0.05% NP-digested with endo-H (Bio Labs, New England), and subsequently
40, and 1 mM DTT). PKD proteins were eluted with the elution bufferanalyzed by SDS- PAGE/autoradiography.
containing 20 mM reduced glutathione. 20 ml of eluted samples
containing 0.5 mg PKD proteins were mixed with 10 ml 50 mM TrisRecombinant DNA
pH 7.4, 30 mM MgCl2, 300 mM ATP, 5 mCi g2[32P]ATP and incubatedPKDwt sequence has been described previously (Valverde et al.,
for 10 min at 328C. The reactions were stopped by adding sample1994). The cDNA was subcloned into the Not1 site of pGMEXT3,
buffer. The proteins were resolved by SDS-PAGE, the gel stainedwhich has a GST tag upstream of the Not1 site. The PKD kinase
with coomassie blue, dried, and analyzed by phosphoimager.inactive K618N clone was constructed by changing the Lysine in
the 618 position to an Aspargine by the Quickchange kit, according
to the instructions of the manufacturer. pME-Neo-GF-PKD-K618N Cell Permeabilization
The cell permeabilization assay used is a modification of Acharyaplasmid was constructed by subcloning the SalI-XbaI fragment from
pGMEXT3-PKD-K618N into pME-Neo-GF vector, which has a neo- et al. (1998). Briefly, HeLa cells were grown on Pronectin F-coated
glass coverslips and then transfected with PKD-K618N GFP. Thesemycin resistance gene and GST and FLAG tandem tag for making
PKD-Mediated Transport Carrier Formation
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cells were washed at room temperature in KHM buffer (25 mM Johannes, F.J., Prestle, J., Eis, S., Oberhagemann, P., and Pfizen-
maier, K. (1994). PKCm is a novel, atypical member of the proteinHepes-KOH [pH 7.2], 125 mM potassium acetate, 2.5 mM magne-
sium acetate), shifted to ice, washed with cold KHM, and permeabil- kinase C family. J. Biol. Chem. 269, 6140–6148.
ized with 30 mg/ml digitonin in KHM. The cells were incubated at Karlsson, L., Peleraux, A., Lindstedt, R., Liljedahl, M., and Peterson,
328C for 45 min with 100 mM GTPgS and ATP regeneration system P.A. (1994). Reconstitution of an operational MHC class II compart-
in KHM buffer. ment in nonantigen-presenting cells. Science 266, 1569–1573.
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